Review explores critical role of microbiome in cancer development and treatment
Peer-Reviewed Publication
Updates every hour. Last Updated: 7-Sep-2025 21:11 ET (8-Sep-2025 01:11 GMT/UTC)
A comprehensive review published in iMeta synthesizes current evidence on how the microbiome (including bacteria, viruses, and fungi) shapes cancer biology. The study highlights microbial influences on tumor development, immune modulation, therapy response, and potential diagnostic and therapeutic applications, underscoring the microbiome’s promise as a target for next-generation oncology strategies.
Researchers at the Antimicrobial Resistance (AMR) interdisciplinary research group of the Singapore-MIT Alliance for Research and Technology (SMART), Massachusetts Institute of Technology’s (MIT) research enterprise in Singapore, have developed a powerful tool capable of scanning thousands of biological samples to detect transfer ribonucleic acid (tRNA) modifications — tiny chemical changes to RNA molecules that help control how cells grow, adapt to stress and respond to diseases such as cancer and antibiotic‑resistant infections.
This news article reports on a study revealing the importance of the proboscis monkey's large nose in vocal communication. Researchers used CT scans and computer simulations to demonstrate that the nose's shape modifies the resonant frequencies of calls, creating unique vocal signatures for individual monkeys. This discovery highlights the role of the nose in enhancing vocal identity and provides insights into the evolution of communication, not just in proboscis monkeys but potentially in other species as well. The collaboration between scientists and the Yokohama Zoo Zoorasia opens exciting new avenues for understanding the link between physical traits and social behaviors in the animal kingdom.
Clinicians’ ability to diagnose and treat chronic diseases is limited by scientific uncertainty around factors contributing to disease risk. A study published September 2nd in the open-access journal PLOS Biology by Drs. Emily Van Syoc, Emily Davenport, and Seth Bordenstein at The Pennsylvania State University, United States, uncovers evidence of the first ternary relationships between human genetic variation, variation in gut mycobiome, and risk of developing chronic disease.